Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction - a randomised placebo-controlled trial (KARE): study protocol
Trials. 2017 May 11;18(1):214.
doi: 10.1186/s13063-017-1930-7.
1 Centre for Infection and Immunity, The Queen's University of Belfast, Health Sciences, Building, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland.
2 Regional Intensive Care Unit, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland.
3 Clinical Research Support Centre, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland.
4 Cardiovascular Research Institute, University of California, San Francisco, 505 Parnassus Avenue, M-917, San Francisco, CA, 94143-0624, USA.
5 Departments of Medicine and Anesthesia, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94143, USA.
6 Centre for Infection and Immunity, The Queen's University of Belfast, Health Sciences, Building, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland. d.f.mcauley@qub.ac.uk.
7 Regional Intensive Care Unit, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland. d.f.mcauley@qub.ac.uk.